Coenzyme Q10 in Older Athletes Treated With Statin Medications
NCT ID: NCT01026311
Last Updated: 2012-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
20 participants
INTERVENTIONAL
2009-11-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
NCT01032993
Effects of Coenzyme Q10 Supplementation on Oxidative Stress, Antioxidant Capacity, Inflammatory Responses, Fatigue Elimination, and Exercise Performance in Athletes
NCT03321110
Bioavailability and Impact of Coenzyme Q10 in Stressing Exercise in Senescence Athletes
NCT03893864
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
NCT02597023
Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
NCT02921659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
placebo
1 placebo q d during treatment period
Coenzyme Q10
200mg of coenzyme Q10
Coenzyme q 10
200 mg of Coenzyme q 10
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coenzyme q 10
200 mg of Coenzyme q 10
placebo
1 placebo q d during treatment period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients on a stable dose of statin medication for at least 3 months prior to enrollment in the study
* Self-Described Athletes with any of the following characteristics:
* Participation in a competitive athletic event within the past year or currently training for a competitive athletic event within the 6 months following enrollment
* Regular exercise activity of at least 45 minutes duration 5 times per week
Exclusion Criteria
* CPK level at baseline greater than two times the upper limits of normal
* LDL level at baseline greater than 160 for those without a cardiovascular risk or cardiovascular risk equivalent
* LDL level at baseline greater than 130 for those with a cardiovascular risk or cardiovascular risk equivalent
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Richard Deichmann, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Deichmann, MD
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Deichmann, MD
Role: PRINCIPAL_INVESTIGATOR
Ochsner
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.